This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Jazz Pharmaceuticals Ireland Limited. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Mi Rim Choi: Innovator in Recombinant L-Asparaginase
Introduction
Mi Rim Choi is a notable inventor based in Encino, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of treatments for diseases that can be managed through asparagine depletion. With a total of 2 patents, her work is paving the way for innovative therapeutic solutions.
Latest Patents
Among her latest patents is the invention titled "Dosing and Administration of Recombinant L-Asparaginase." This invention provides compositions and methods for treating diseases that are treatable by asparagine depletion in human subjects. The method involves administering recombinant L-asparaginase to patients, showcasing her commitment to advancing medical treatments.
Career Highlights
Mi Rim Choi is currently associated with Jazz Pharmaceuticals Ireland Limited, where she continues to work on groundbreaking research and development. Her expertise in biotechnology and her innovative approach have positioned her as a key player in her field.
Collaborations
Throughout her career, Mi Rim has collaborated with esteemed colleagues such as Tong Lin and Jeffrey Silverman. These partnerships have further enhanced her research and contributed to the success of her inventions.
Conclusion
Mi Rim Choi's contributions to the field of biotechnology, particularly through her patents on recombinant L-asparaginase, highlight her role as an influential inventor. Her work not only demonstrates her innovative spirit but also her dedication to improving patient outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
